Pharmacists in Centralia, Illinois


13 Pharmacists found in Centralia
female pharmacist

Alicia Lee Wuebbels, RPH


Pharmacist
817 E Mccord St, Centralia, IL 62801
618-533-3300     618-533-3302

male pharmacist

Dr. Blake Edward Knapp, PHARM. D.


Pharmacist
225 N Elm St, Centralia, IL 62801
618-533-5395     618-533-5506

female pharmacist

Brenda S Allen, B.S


Pharmacist
225 N Elm St, Centralia, IL 62801
618-533-5395     618-533-5506



female pharmacist

Dr. Danielle Vahlkamp, PHARMD., D.C.



225 N Poplar St, Centralia, IL 62801
618-532-4158    

female pharmacist

Diann H Brammeier


Pharmacist
1212 W Mccord St, Centralia, IL 62801
618-533-1728    

female pharmacist

Julie Langenfeld


Pharmacist
1071 W Broadway, Centralia, IL 62801
618-532-2200    

female pharmacist

Katelyn Starr, PHARM D


Pharmacist
225 N Elm St, Centralia, IL 62801
618-533-5395    

female pharmacist

Kimberly Wieter, RPH


Pharmacist
1071 W Broadway, Centralia, IL 62801
618-532-2200     618-533-0566

female pharmacist

Lindsay J. Garrison


Pharmacist
1212 W Mccord St, Centralia, IL 62801
618-533-1728     618-533-1734

female pharmacist

Lindsey Tucker, PHARMD


Pharmacist
1212 W Mccord St, Centralia, IL 62801
618-533-1728    

female pharmacist

Nicole Renee Erwin, RPH


Pharmacist
225 N Elm St, Centralia, IL 62801
618-533-5395    

female pharmacist

Rebecca Kae Kutchma, PHARMD


Pharmacist
1212 W Mccord St, Centralia, IL 62801
618-533-1728    

male pharmacist

William H Wantland Jr., RPH


Pharmacist
225 N Poplar St, Centralia, IL 62801
618-532-4158    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.